Trial record 1 of 2 for:    Seciera
Previous Study | Return to List | Next Study

An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02845674
Recruitment Status : Completed
First Posted : July 27, 2016
Last Update Posted : September 19, 2017
Information provided by (Responsible Party):
Ocular Technologies SARL

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 15, 2017
  Actual Study Completion Date : August 15, 2017